Immuron (IMRN) Inventory Average (2017 - 2025)
Immuron (IMRN) posted quarterly Inventory Average of $576401.9 for Q3 2025, up 8.74% year-over-year from $530070.8 in Q3 2024, and down 45.8% quarter-over-quarter from $1.1 million in Q2 2025.
Immuron (IMRN) Inventory Average (2017 - 2025) Analysis & Trends
Immuron's Inventory Average history runs 9 years deep, the most recent figure standing at $576401.9 for Q3 2025.
- In Q3 2025, Inventory Average rose 8.74% year-over-year to $576401.9; the TTM figure through Sep 2025 stood at $576401.9 (up 8.74% YoY), while the FY2025 annual figure was $583222.0, up 10.55% from the prior year.
- Inventory Average for Q3 2025 stood at $576401.9, down from $1.1 million in the prior quarter.
- The five-year high for Inventory Average was $1.1 million in Q2 2025, with the low at $121244.6 in Q2 2021.
- The 5-year median for Inventory Average is $576308.5 (2021), against an average of $615171.8.
- The sharpest annual moves came in 2021 and 2022: Inventory Average slumped 85.47% in 2021, then surged 661.48% in 2022.
- Immuron's Inventory Average stood at $576215.2 in 2021, then climbed by 12.3% to $647101.5 in 2022, then slumped by 37.41% to $404998.8 in 2023, then increased by 24.41% to $503871.0 in 2024, then advanced by 14.39% to $576401.9 in 2025.
- Business Quant data shows IMRN's Inventory Average at $576401.9 in Q3 2025, $1.1 million in Q2 2025, and $503871.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - | 576,401.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 576,401.87 |
| Jun 30, 2025 | 1.06 Mn |
| Dec 31, 2024 | 503,870.97 |
| Sep 9, 2024 | 530,070.78 |
| Jun 30, 2024 | 527,419.94 |
| Dec 31, 2023 | 404,998.85 |
| Sep 28, 2023 | 405,824.88 |
| Aug 30, 2023 | 615,921.23 |
| Jun 30, 2023 | 924,186.91 |
| Dec 31, 2022 | 647,101.50 |
| Aug 31, 2022 | 792,407.80 |
| Jun 30, 2022 | 923,252.50 |
| Dec 31, 2021 | 576,215.18 |
| Jun 30, 2021 | 121,244.63 |
| Dec 31, 2020 | 869,786.25 |
| Sep 1, 2020 | 1.69 Mn |
| Jun 30, 2020 | 834,454.51 |
| Dec 31, 2019 | 660,773.50 |
| Jun 30, 2019 | 1.74 Mn |
| Dec 31, 2018 | 1.88 Mn |